544 related articles for article (PubMed ID: 25386049)
1. Current surgical treatment strategies for hepatocellular carcinoma in North America.
Khan AS; Fowler KJ; Chapman WC
World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
[TBL] [Abstract][Full Text] [Related]
2. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the surgical treatment of hepatocellular carcinoma.
Morise Z; Kawabe N; Tomishige H; Nagata H; Kawase J; Arakawa S; Yoshida R; Isetani M
World J Gastroenterol; 2014 Oct; 20(39):14381-92. PubMed ID: 25339825
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
Gunsar F
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
[TBL] [Abstract][Full Text] [Related]
6. Necrosis percentage of radiologically treated hepatocellular carcinoma at hepatectomy for liver transplantation.
Rossetto A; Adani GL; Baccarani U; Bresadola V; Lorenzin D; Sponza M; Vit A; De Anna D; Bresadola F
Transplant Proc; 2011 May; 43(4):1095-7. PubMed ID: 21620061
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the current surgical strategies for hepatocellular carcinoma.
Takamoto T; Sugawara Y; Hashimoto T; Makuuchi M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):341-57. PubMed ID: 26558422
[TBL] [Abstract][Full Text] [Related]
9. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
10. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
Giacomoni A; Concone G; Di Sandro S; Lauterio A; De Carlis L
Transplantation; 2015 Sep; 99(9):e155-6. PubMed ID: 26308419
[No Abstract] [Full Text] [Related]
12. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
Izumi N
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
[TBL] [Abstract][Full Text] [Related]
15. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
[TBL] [Abstract][Full Text] [Related]
16. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
19. [Loco-regional therapy for liver malignancy in Iceland].
Bjarnason TA; Bjarnason H; Bergmann OM; Thorisson HM
Laeknabladid; 2012 Jun; 98(6):334-40. PubMed ID: 22647444
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]